Browse Pet Safety Reports
143,870 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 143,870 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 143,870 FDA veterinary adverse event reports for Cat.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Apr 6, 2025 | Cat | Crossbred Feline/cat | Eprinomectin; Praziquantel; Esafoxolaner | Lethargy (see also Central nervous system depression in Neurological); Dilate... | Outcome Unknown |
| Apr 6, 2025 | Cat | Cat (other) | Selamectin;Sarolaner | Lack of efficacy (endoparasite) - tapeworm; Lack of efficacy (ectoparasite) -... | Outcome Unknown |
| Apr 6, 2025 | Cat | Cat (other) | Selamectin;Sarolaner | Application site hair loss | Outcome Unknown |
| Apr 6, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site alopecia; Application site crust | Outcome Unknown |
| Apr 5, 2025 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Inappetence; Lethargy (see also Central nervous system depression in Neurolog... | Ongoing |
| Apr 5, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Weight loss; Ketosis; Lethargy (see also Central nervous system depression in... | Ongoing |
| Apr 5, 2025 | Cat | Domestic Longhair | Bexagliflozin | Soft stool; Ketosis; Vomiting; Hyperglycaemia; Behavioural disorder NOS | Ongoing |
| Apr 5, 2025 | Cat | Cat (unknown) | Buprenorphine | Application site reddening; Application site hair loss; Application site itching | Ongoing |
| Apr 5, 2025 | Cat | Cat (unknown) | Buprenorphine | Application site alopecia; Application site scab | Ongoing |
| Apr 5, 2025 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Skin lesion NOS; Crust; General hair loss; Itching | Ongoing |
| Apr 5, 2025 | Cat | Domestic Shorthair | Frunevetmab | Decreased appetite | Ongoing |
| Apr 5, 2025 | Cat | Domestic Shorthair | Fluralaner/Moxidectin Spot-On | Application site pain; Application site alopecia; Licking at application site... | Ongoing |
| Apr 5, 2025 | Cat | Domestic Longhair | Bexagliflozin | Diarrhoea | Ongoing |
| Apr 5, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Diarrhoea; Lethargy (see also Central nervous system depression in Neurologic... | Outcome Unknown |
| Apr 5, 2025 | Cat | Domestic Longhair | Toceranib Phosphate | Pigmentation disorder; Intentional misuse | Ongoing |
| Apr 5, 2025 | Cat | Cat (other) | Oxytetracycline Hcl;Polymyxin B Sulfate | Anisocoria | Ongoing |
| Apr 5, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Gagging; Foaming at the mouth; Sneezing | Recovered/Normal |
| Apr 5, 2025 | Cat | Domestic Longhair | Frunevetmab | Ataxia; Wide-base stance; Musculoskeletal disorder NOS | Ongoing |
| Apr 5, 2025 | Cat | Cat (unknown) | Thiamazole | Not eating | Outcome Unknown |
| Apr 5, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Application site hair change; Application site hair loss | Outcome Unknown |
| Apr 5, 2025 | Cat | Domestic Shorthair | Frunevetmab | Urinary incontinence; Increased urine volume; Inappropriate elimination NOS | Outcome Unknown |
| Apr 5, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Inappropriate urination; Not eating; Weight loss | Outcome Unknown |
| Apr 5, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS | Outcome Unknown |
| Apr 5, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Allergic reaction; Reddening of the skin; Skin lesion NOS; Hair loss NOS; App... | Outcome Unknown |
| Apr 5, 2025 | Cat | Domestic Mediumhair | Fluralaner/Moxidectin Spot-On | Ataxia; Stumbling gait; Behavioural disorder NOS | Recovered/Normal |
| Apr 5, 2025 | Cat | Siamese, Maine Coon | Selamectin;Sarolaner | Seizure NOS; Head shake - behavioural disorder; Ear twitching; Head tremor | Recovered/Normal |
| Apr 5, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Application site hair change; Application site hair loss | Outcome Unknown |
| Apr 5, 2025 | Cat | Domestic Shorthair | Frunevetmab | Weight loss; Renal insufficiency | Ongoing |
| Apr 5, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Application site hair change; Drooling; Vocalisation; Application site hair loss | Outcome Unknown |
| Apr 5, 2025 | Cat | Cat (unknown) | Molidustat Sodium | Lack of efficacy - NOS | Outcome Unknown |
| Apr 5, 2025 | Cat | Domestic Shorthair | Cefovecin | Lethargy (see also Central nervous system depression in Neurological); Skin d... | Recovered/Normal |
| Apr 5, 2025 | Cat | Domestic Shorthair | Nitenpyram | Shaking; Hyperactivity; Behavioural disorder NOS; Panting; Tongue protrusion;... | Recovered/Normal |
| Apr 5, 2025 | Cat | Domestic Shorthair | Buprenorphine | Not sleeping; Mental confusion; Hallucination; Restlessness; Neurological dis... | Recovered/Normal |
| Apr 5, 2025 | Cat | Cat (other), Domestic Short... | Cefovecin Sodium | Vomiting; Not eating; Elevated alanine aminotransferase (ALT); Lack of effica... | Outcome Unknown |
| Apr 4, 2025 | Cat | Domestic Shorthair | Cefovecin Sodium | Injection site mass NOS; Injection site swelling; Injection site necrosis; Li... | Outcome Unknown |
| Apr 4, 2025 | Cat | Domestic Shorthair | Cefovecin | Anaphylaxis; Open mouth breathing; Drooling | Recovered/Normal |
| Apr 4, 2025 | Cat | Domestic Shorthair | Tigilanol Tiglate | Injection site lesion; Injection site reaction NOS; Medication error NOS | Recovered/Normal |
| Apr 4, 2025 | Cat | Domestic Shorthair | Thiamazole | Localised itching; Localised hair loss | Recovered/Normal |
| Apr 4, 2025 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Application site erythema; Application site alopecia; Application site scab; ... | Ongoing |
| Apr 4, 2025 | Cat | Domestic Shorthair | Dexmedetomidine Hydrochloride | Intentional misuse; Hypotension; Lack of efficacy - NOS | Recovered/Normal |
| Apr 4, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Vomiting; Lethargy (see also Central nervous system depression in Neurologica... | Euthanized |
| Apr 4, 2025 | Cat | Cat (unknown) | Velagliflozin Proline Monohydrate | Ketosis | Outcome Unknown |
| Apr 4, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site hair loss; Application site scab | Ongoing |
| Apr 4, 2025 | Cat | Domestic Shorthair | Methimazole | Behavioural disorder NOS; Hypotension; Elevated symmetrical dimethylarginine ... | Outcome Unknown |
| Apr 4, 2025 | Cat | Domestic Longhair | Velagliflozin Proline Monohydrate | Decreased appetite; Weight loss | Outcome Unknown |
| Apr 4, 2025 | Cat | Cat (unknown) | Bexagliflozin | Ketosis | Ongoing |
| Apr 4, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Drooling; Scratching; Licking at application site; Lack of efficacy (ectopara... | Outcome Unknown |
| Apr 4, 2025 | Cat | Domestic Shorthair | Dexmedetomidine Hydrochloride | Intentional misuse; Heart block 2nd degree; Hypotension | Recovered/Normal |
| Apr 4, 2025 | Cat | Domestic Mediumhair | Fluralaner/Moxidectin Spot-On | Lack of efficacy (ectoparasite) - flea; Lack of efficacy (ectoparasite) - tic... | Ongoing |
| Apr 4, 2025 | Cat | Domestic Shorthair | Frunevetmab | Low thyroxine (T4); Elevated creatinine; Weight loss; Decreased appetite; Ele... | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.